Announced
Livzon Pharmaceutical Group to acquire a 65% stake in Imexpharm for $219m.
Synopsis
Livzon Pharmaceutical Group, a pharmaceutical company in China, agreed to acquire a 65% stake in Imexpharm, a pharmaceutical enterprise in Vietnam, for $219m. The transaction remains subject to regulatory approval, including compliance with Vietnam's foreign ownership cap.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Bidder Team (3)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite